Patient choice and policy advocacy go hand in hand in HIV prevention
|
Offering accessible options like injectable PrEP can
transform care for vulnerable populations. Yet, even with medical
breakthroughs, ... |
New once-weekly HIV pill matches daily treatment in phase 3 trial
Living with HIV often means taking antiretroviral treatment every day to keep the virus under control. While modern HIV medicines have made it ... View article...